Jaime L. Schneider

Also affiliated with Dana-Farber Cancer Institute

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers”.

Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3467

N/A

0DataRank · unranked

143 citations

Amikasra Mojtahed, Jaime L. Schneider, Katie Kanter, Emily E. Van Seventer, Isobel J. Fetter +25 more

The aging lung: Physiology, disease, and immunity

Cell(2021)10.1016/j.cell.2021.03.005

N/A

0DataRank · unranked

483 citations

Jared H. Rowe, Carolina Garcia-de-Alba, Carla F. Kim, Arlene H. Sharpe, Marcia C. Haigis +1 more

Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100187

N/A

0DataRank · unranked

33 citations

Jaime L. Schneider, Tejas Patil, Viola W. Zhu, Debra A. Goldman, Soo-Ryum Yang +13 more

ALK-positive lung cancer: a moving target

Nature Cancer(2023)10.1038/s43018-023-00515-0

N/A

0DataRank · unranked

173 citations

W. Marston Linehan, Alice T. Shaw, Jaime L. Schneider

Lorlatinib and capmatinib in a ROS1-rearranged NSCLC with MET-driven resistance: tumor response and evolution

npj Precision Oncology(2023)10.1038/s41698-023-00464-y

N/A

0DataRank · unranked

8 citations

Khvaramze Shaverdashvili, Mari Mino–Kenudson, Subba R. Digumarthy, Andrew Do, Audrey Liu +5 more

GUK1 activation is a metabolic liability in lung cancer

Cell(2025)10.1016/j.cell.2025.01.024

N/A

0DataRank · unranked

16 citations

Kiran Kurmi, Yutong Dai, Ishita Dhiman, Shakchhi Joshi, Brandon M. Gassaway +21 more

Projecting individualized probabilities of lifetime all-cancer risk

medRxiv(2025)10.1101/2025.07.23.25326097

N/A

0DataRank · unranked

0 citations

Noor Al‐Hammadi, Asiri Ediriwickrema, Jaime L. Schneider, Aaron Fullerton, Jeya Balaji Balasubramanian +3 more